Ledipasvir/Sofosbuvir plus Ribavirin (LDV/SOF+RBV) for 12 Weeks in Decompensated HCV Genotype 1 Patients: SOLAR-1 and-2 Studies Compared to a Real-World Dataset
dc.contributor.author | Charlton, MR | en_US |
dc.contributor.author | Cheung, MC | en_US |
dc.contributor.author | Manns, MP | en_US |
dc.contributor.author | Sajed, N | en_US |
dc.contributor.author | Troke, P | en_US |
dc.contributor.author | Spellman, JG | en_US |
dc.contributor.author | Copans, A | en_US |
dc.contributor.author | Arterburn, S | en_US |
dc.contributor.author | Brainard, DM | en_US |
dc.contributor.author | Irving, W | en_US |
dc.contributor.author | Foster, GR | en_US |
dc.date.accessioned | 2017-06-01T14:11:52Z | |
dc.date.issued | 2016-10 | en_US |
dc.date.submitted | 2017-01-04T08:27:07.136Z | |
dc.identifier.issn | 0270-9139 | en_US |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/23495 | |
dc.description | Meeting Abstract | en_US |
dc.description.sponsorship | Amer Assoc Study Liver Dis | en_US |
dc.format.extent | 489A - 490A | en_US |
dc.title | Ledipasvir/Sofosbuvir plus Ribavirin (LDV/SOF+RBV) for 12 Weeks in Decompensated HCV Genotype 1 Patients: SOLAR-1 and-2 Studies Compared to a Real-World Dataset | en_US |
dc.type | Conference Proceeding | |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000385493802233&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 64 | en_US |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |
This item appears in the following Collection(s)
-
Centre for Immunobiology [1121]